Immunotherapy and Targeted Therapies in Treatment of Visceral Leishmaniasis: Current Status and Future Prospects

Visceral leishmaniasis (VL) is a vector-borne chronic infectious disease caused by the protozoan parasite Leishmania donovani or Leishmania infantum. VL is a serious public health problem, causing high morbidity and mortality in the developing world with an estimated 0.2–0.4 million new cases each y...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Om Prakash, Sundar, Shyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135235/
https://www.ncbi.nlm.nih.gov/pubmed/25183962
http://dx.doi.org/10.3389/fimmu.2014.00296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135235/
https://www.ncbi.nlm.nih.gov/pubmed/25183962
http://dx.doi.org/10.3389/fimmu.2014.00296

Ejemplares similares